These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 13796179)

  • 1. Studies on cross tolerance with LSD-25, UML-491 and JB_336.
    BALESTRIERI A
    Psychopharmacologia; 1960 Feb; 1():257-9. PubMed ID: 13796179
    [No Abstract]   [Full Text] [Related]  

  • 2. Lysergic acid diethylamide (LSD 25). 36. Comparison of effect of methysergide (UML 491) on goldfish and Siamese fighting fish.
    Gettner HH; Rolo A; Abramson HA
    J Psychol; 1965 Sep; 61(1):87-92. PubMed ID: 5834759
    [No Abstract]   [Full Text] [Related]  

  • 3. Cross tolerance between LSD and psilocybin.
    ISBELL H; WOLBACH AB; WIKLER A; MINER EJ
    Psychopharmacologia; 1961; 2():147-59. PubMed ID: 13717955
    [No Abstract]   [Full Text] [Related]  

  • 4. Dual actions of lysergic acid diethylamide tartrate (LSD), 2-bromo-D-lysergic acid diethylamide bitartrate (BOL) and methysergide on dorsal root potentials evoked by stimulation of raphe nuclei.
    Larson AA; Chinn C; Proudfit HK; Anderson EG
    J Pharmacol Exp Ther; 1981 Apr; 217(1):99-104. PubMed ID: 6110778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Psychopsychic correlations under the effect of psycholytics (LSD, psilocybin and similar drugs)].
    HOLFELD H
    Med Exp Int J Exp Med; 1961; 5():209-14. PubMed ID: 13908338
    [No Abstract]   [Full Text] [Related]  

  • 6. Cross tolerance between D-2-brom-lysergic acid diethylamide (BOL-148) and the D-diethylamide of lysergic acid (LSD-25).
    ISBELL H; MINER EJ; LOGAN CR
    Psychopharmacologia; 1959 Nov; 1():109-16. PubMed ID: 14405871
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [LSD-25 and UML decrease the levels of 5-hydroxyindoleacetic acid in the brain of rat].
    Torre M; Bogetto F; Torre E
    Boll Soc Ital Biol Sper; 1976 Nov; 52(21):1835-7. PubMed ID: 1026256
    [No Abstract]   [Full Text] [Related]  

  • 9. [Conditioned flight reflex in the rat: crosses habituation between LSD-25 and UML].
    Torre M; Fagiani MB; Torre C
    Boll Soc Ital Biol Sper; 1974 Oct; 50(20):1647-9. PubMed ID: 4464009
    [No Abstract]   [Full Text] [Related]  

  • 10. Lysergic acid diethylamide (LSD-25). 38. Comparison with action of methysergide and psilocybin on test subjects.
    Abramson HA; Rolo A
    J Asthma Res; 1965 Sep; 3(1):81-96. PubMed ID: 5318626
    [No Abstract]   [Full Text] [Related]  

  • 11. [Simultaneous administration of LSD-25 and UML: cerebral levels of serotonin and conditioned behavior in the rat].
    Torre M; Torre E; Bogetto F
    Boll Soc Ital Biol Sper; 1974 Oct; 50(20):1643-6. PubMed ID: 4464008
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled sensory input: a note on the technic of drug evaluation with a preliminary report on a comparative study of sernyl, psilocybin, and LSD-25.
    POLLARD JC; BAKKER C; UHR L; FEUERFILE DF
    Compr Psychiatry; 1960 Dec; 1():377-80. PubMed ID: 13736851
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperthermic effects of D-lysergic acid diethylamide (LSD) and its derivatives in rabbits and rats.
    Hashimoto H; Hayashi M; Nakahara Y; Niwaguchi T; Ishii H
    Arch Int Pharmacodyn Ther; 1977 Aug; 228(2):314-21. PubMed ID: 303504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of lysergic acid diethylamide, methysergide, and cyproheptadine on modality-specific and nonspecific sensory evoked potentials.
    Wilkison DM; Hosko MJ
    Exp Neurol; 1983 Nov; 82(2):391-403. PubMed ID: 6628626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of autistic schizophrenic children with LSD-25 and UML-491.
    BENDER L; GOLDSCHMIDT L; SANKAR DV
    Recent Adv Biol Psychiatry; 1961; 4():170-9. PubMed ID: 13867084
    [No Abstract]   [Full Text] [Related]  

  • 16. The relation between cerebral serotonin levels and conditioned behaviour in the rat following the administration of LSD-25 and UML.
    Torre M; Torre E; Bogetto F
    Psychopharmacologia; 1975; 41(3):245-7. PubMed ID: 1153613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LSD and JB 318: a comparison of two hallucinogens. I. An exploratory study.
    LEBOVITS BZ; VISOTSKY HM; OSTFELD AM
    AMA Arch Gen Psychiatry; 1960 Apr; 2():390-407. PubMed ID: 14415046
    [No Abstract]   [Full Text] [Related]  

  • 18. LSD and JB 318: a comparison of two hallucinogens. III. Qualatative analysis and summary of findings.
    LEBOVITS BZ; VISOTSKY HM; OSTEFELD AM
    Arch Gen Psychiatry; 1962 Jul; 7():39-45. PubMed ID: 14463342
    [No Abstract]   [Full Text] [Related]  

  • 19. Actions of derivatives of lysergic acid on the heart of Venus mercenaria.
    WRIGHT AM; MOCRHEAD M; WELSH JH
    Br J Pharmacol Chemother; 1962 Apr; 18(2):440-50. PubMed ID: 14008412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antagonism of 5-hydroxytryptamine by LSD 25 in the central nervous system: a possible neuronal basis for the actions of LSD 25.
    Boakes RJ; Bradley PB; Briggs I; Dray A
    Br J Pharmacol; 1970 Oct; 40(2):202-18. PubMed ID: 5492893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.